Prostate biopsies can increase risk of hospitalization
Men 65 years or older are more likely to be hospitalized within 30 days after a prostate biopsy than men of the same age…
Web Exclusives
Our Readers Respond
The truth about high-energy drinks Re “High-energy drinks: What you don’t know could hurt you” (August article available here): I am very impressed with…
FDA approves treatment of non-small cell lung cancer
The U.S. Food and Drug Administration (FDA) has approved Xalkori (crizotinib) to treat patients with late-stage non-small cell lung cancers who express the abnormal…
FDA approves treatment for hereditary angioedema
The U.S. Food and Drug Administration (FDA) has approved Firazyr (icatibant) Injection for the treatment of acute attacks of hereditary angioedema in people ages…
Hospital patients with chronic diseases at risk for unintentional stoppage of medications
A study in JAMA found that patients with chronic diseases who are admitted to the hospital are at increased risk for unintentional discontinuation of…
FDA podcast addresses dangers of long-term, high dosage use of Diflucan during pregnancy
The U.S. Food and Drug Administration (FDA) has released a podcast explaining how long-term, high dosage use of Diflucan during pregnancy may be associated…
FDA publishes REMS list
Access a list of Risk Evaluation and Mitigation Strategies (REMS) required by the U.S. Food and Drug Administration (FDA). Read more..
Lancet study suggests 9/11 firefighters may have higher risk of cancer
The Lancet has published a study that reports a “modest excess of cancer cases” in 9/11 New York City firefighters. The researchers caution that…
FDA approves new melanoma drug
The U.S. Food and Drug Administration (FDA) has approved Zelboraf (vemurafenib) for use in patients with metastatic or unresectable melanoma who have the BRAF…
Lancet publishes series on worldwide obesity
The Lancet has published a four-part series on worldwide obesity. The articles can be accessed at no charge, but registration is required. Read more.
TJC releases sentinel event alert on radiation risk of diagnostic imaging
On Aug. 24, The Joint Commission (TJC) published a sentinel event alert on the radiation risk of diagnostic images. It includes actions organizations can…
AHRQ releases Spanish medication tracking tool
The Agency for Healthcare Research and Quality has released a newly revised Spanish language medication tracking tool, “Su medicamento: Infórmese. Evite riesgos.” (“Your Medicine:…
Prostate biopsies can increase risk of hospitalization
Men 65 years or older are more likely to be hospitalized within 30 days after a prostate biopsy than men of the…
Our Readers Respond
The truth about high-energy drinks Re “High-energy drinks: What you don’t know could hurt you” (August article available here): I am very…
FDA approves treatment of non-small cell lung cancer
The U.S. Food and Drug Administration (FDA) has approved Xalkori (crizotinib) to treat patients with late-stage non-small cell lung cancers who express…
FDA approves treatment for hereditary angioedema
The U.S. Food and Drug Administration (FDA) has approved Firazyr (icatibant) Injection for the treatment of acute attacks of hereditary angioedema in…
Hospital patients with chronic diseases at risk for unintentional stoppage of medications
A study in JAMA found that patients with chronic diseases who are admitted to the hospital are at increased risk for unintentional…
FDA podcast addresses dangers of long-term, high dosage use of Diflucan during pregnancy
The U.S. Food and Drug Administration (FDA) has released a podcast explaining how long-term, high dosage use of Diflucan during pregnancy may…
FDA publishes REMS list
Access a list of Risk Evaluation and Mitigation Strategies (REMS) required by the U.S. Food and Drug Administration (FDA). Read more..
Lancet study suggests 9/11 firefighters may have higher risk of cancer
The Lancet has published a study that reports a “modest excess of cancer cases” in 9/11 New York City firefighters. The researchers…
FDA approves new melanoma drug
The U.S. Food and Drug Administration (FDA) has approved Zelboraf (vemurafenib) for use in patients with metastatic or unresectable melanoma who have…
Lancet publishes series on worldwide obesity
The Lancet has published a four-part series on worldwide obesity. The articles can be accessed at no charge, but registration is required.…
TJC releases sentinel event alert on radiation risk of diagnostic imaging
On Aug. 24, The Joint Commission (TJC) published a sentinel event alert on the radiation risk of diagnostic images. It includes actions…
AHRQ releases Spanish medication tracking tool
The Agency for Healthcare Research and Quality has released a newly revised Spanish language medication tracking tool, “Su medicamento: Infórmese. Evite riesgos.”…
Test Your Knowledge
Emotional Intel TYK
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.